查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564990

血塊管理設備的全球市場

Clot Management Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血栓管理設備市場預計將達到 29 億美元

2023 年全球血栓管理設備市場估計為 21 億美元，預計到 2030 年將達到 29 億美元，2023-2030 年分析期間複合年成長率為 4.6%。經皮血栓切除裝置是本報告分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 11 億美元。在分析期間，導管直接溶栓 (CDT) 設備領域的複合年成長率預計為 4.0%。

美國市場預計將達到5.799億美元，中國預計複合年成長率為4.4%。

預計 2023 年美國血栓管理設備市場規模將達 5.799 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到4.634億美元，2023-2030年分析期間複合年成長率為4.4%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.2% 和 3.8%。在歐洲，德國的複合年成長率預計為 4.6%。

全球血栓管理設備市場—主要趨勢與促進因素總結

為什麼血塊管理設備成為現代醫學的重要工具？

由於血栓形成引起的疾病（例如深層靜脈栓塞症（DVT）、肺動脈栓塞（PE）和缺血性中風）的盛行率不斷增加，血栓管理裝置在現代醫學中受到了極大的關注。這些疾病造成嚴重的健康風險，包括危及生命的併發症，如心臟病、中風和慢性靜脈功能不全。心血管疾病的增加、人口老化以及肥胖和久坐生活方式等與生活方式相關的危險因素，都導致需要採取干涉措施清除和管理血栓的病例迅速增加。用於溶解、移除和預防血栓的血栓管理裝置被認為是改善患者預後和降低長期併發症風險的重要工具。隨著微創手術的出現，這些設備已成為首選的治療選擇，因為它們比開放性手術和長期抗凝血等傳統方法提供更快的恢復、更少的併發症和更有針對性的治療方法。

科技進步如何改變血塊管理解決方案？

由於技術進步使手術過程更安全、更快速、更有效，血塊管理設備的前景正在迅速發展。最重要的進步之一是機械血栓切除裝置領域，該裝置旨在物理去除動脈和靜脈中的血塊，通常是在微創、基於導管的手術過程中進行。這些設備可以及時清除血塊，恢復大腦的血流並防止永久性損傷，徹底改變了缺血性中風的治療方法。此外，直接導管溶栓（將溶栓劑直接施用到凝塊部位）已顯示出準確性和安全性的提高。抽吸導管（利用吸力去除血塊）和旋轉血栓切除系統（將血塊分解成更小的碎片以便於處理）等設備在臨床上擴大用於治療 DVT 和 PE。此外，生物可吸收血栓移除裝置和血栓摘取支架的開發提供了侵入性較小、長期併發症較少的選擇。這些進步不僅提高了血栓管理設備的有效性，而且還為治療複雜的高風險患者開闢了新途徑，並將這些技術擴展到更廣泛的醫療環境中的使用。

血栓管理設備在哪些方面影響最大？

事實證明，血栓管理設備在多個醫療領域可以挽救生命，特別是在循環系統、神經科和急診醫學領域。在循環系統中，血栓管理裝置的使用對於治療急性冠狀動脈症候群和靜脈血栓栓塞症(VTE) 至關重要。這些設備可以快速恢復血液流動，並有助於防止血栓形成，血栓形成可能導致心臟病和其他嚴重併發症。在神經病學中，機械血栓切除裝置被認為是治療大血管閉塞引起的缺血性中風的黃金標準。在關鍵時間內快速清除血栓可以顯著改善神經系統結果並降低長期殘疾的風險。在急診醫學中，血栓管理設備用於快速解決危及生命的栓塞和靜脈閉塞，加快患者康復速度並減輕加護治療資源的整體負擔。此外，癌症患者、長時間不動的患者以及有遺傳傾向的患者中血栓相關疾病的盛行率不斷增加，導致這些設備在更廣泛的醫療機構（從加護病房）中使用門診診所的需求正在成長。隨著醫療保健相關人員不斷完善血栓管理通訊協定，這些設備對提高血栓性疾病患者的生存率和生活品質有重大影響。

促進血栓管理設備市場擴張的因素有哪些？

血栓管理設備市場的成長是由心血管疾病、中風和靜脈血栓栓塞症發病率上升等多種因素所推動的。世界人口老化是一個主要因素，老年人由於血液循環減少、合併症和長時間不動而面臨更高的血栓風險。此外，肥胖、久坐的生活方式和吸煙等生活習慣進一步加劇了需要血栓管理干預措施的疾病的盛行率。該市場也受到技術進步的推動，這些技術進步使血栓切除術更安全、更快速、更容易獲得。機械取栓設備（例如血栓摘取支架和抽吸系統）的創新極大地改善了患者的治療效果，特別是在中風治療方面。微創手術的日益普及，與傳統手術相比，恢復時間更短，併發症更少，也是市場擴張的關鍵驅動力。此外，隨著醫療保健提供者專注於縮短住院時間和改善長期結果，對能夠快速有效去除血栓的設備的需求不斷增加。有利的報銷政策，尤其是在新興市場，以及醫生和患者對及時血栓干預重要性的認知不斷提高，進一步推動了市場的發展。隨著血栓相關疾病的發病率持續上升，由於這些不同的因素，對先進血栓管理設備的需求預計將顯著成長。

受訪企業範例（11家知名企業）

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular SLU
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP11053

Global Clot Management Devices Market to Reach US$2.9 Billion by 2030

The global market for Clot Management Devices estimated at US$2.1 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Catheter-Directed Thrombolysis (CDT) Devices segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$579.9 Million While China is Forecast to Grow at 4.4% CAGR

The Clot Management Devices market in the U.S. is estimated at US$579.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$463.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Clot Management Devices Market - Key Trends and Drivers Summarized

Why Are Clot Management Devices Becoming a Critical Tool in Modern Medicine?

Clot management devices have gained significant attention in modern medicine due to the increasing prevalence of conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic strokes, which are all caused by the formation of blood clots. These conditions pose serious health risks, including life-threatening complications like heart attacks, strokes, and chronic venous insufficiency. The growing incidence of cardiovascular diseases, an aging population, and lifestyle-related risk factors such as obesity and sedentary behavior have all contributed to a surge in cases requiring intervention for blood clot removal or management. Clot management devices, designed to either dissolve, remove, or prevent blood clots, are seen as critical tools in improving patient outcomes and reducing the risk of long-term complications. With the advent of minimally invasive procedures, these devices have become a preferred treatment option over traditional methods like open surgery or long-term anticoagulant therapy, as they offer quicker recovery times, fewer complications, and more targeted treatment approaches.

How Are Technological Advancements Transforming Clot Management Solutions?

The clot management device landscape has evolved rapidly thanks to technological advancements that are making procedures safer, faster, and more effective. One of the most significant developments is in the area of mechanical thrombectomy devices, which are designed to physically remove clots from arteries or veins, typically during minimally invasive catheter-based procedures. These devices have revolutionized the treatment of ischemic strokes by allowing for timely removal of clots, thereby restoring blood flow to the brain and preventing permanent damage. Additionally, catheter-directed thrombolysis, where clot-dissolving agents are delivered directly to the site of the clot, has seen improvements in both precision and safety. Devices such as aspiration catheters, which use suction to remove clots, and rotational thrombectomy systems, which break clots into smaller, more manageable pieces, are increasingly being utilized in clinical practice to treat DVT and PE. Furthermore, the development of bioabsorbable clot retrieval devices and stent retrievers provides a less invasive option with fewer long-term complications. These advancements are not only improving the efficacy of clot management devices but are also opening new avenues for the treatment of complex and high-risk patients, expanding the use of these technologies in broader medical settings.

Where Are Clot Management Devices Making the Greatest Impact?

Clot management devices have proven to be life-saving in a variety of medical fields, particularly in cardiology, neurology, and emergency medicine. In cardiology, the use of clot management devices is critical in treating acute coronary syndromes and venous thromboembolism (VTE), which includes both DVT and PE. These devices help to quickly restore blood flow and prevent the progression of clots that can lead to heart attacks or other serious complications. In neurology, mechanical thrombectomy devices are now considered the gold standard for treating ischemic strokes caused by large vessel occlusions. Rapid clot removal within the crucial time window can significantly improve neurological outcomes and reduce the risk of long-term disability. In emergency medicine, clot management devices are used to quickly address life-threatening embolisms or venous blockages, allowing patients to recover more rapidly and reducing the overall strain on intensive care resources. The rising prevalence of clot-related conditions in patients with cancer, long-term immobility, or genetic predispositions has also increased the need for these devices across a broader range of healthcare settings, from intensive care units to outpatient clinics. As medical professionals continue to refine clot management protocols, these devices are making a profound impact on improving survival rates and quality of life for patients with thrombotic diseases.

What Factors are Driving the Expansion of the Clot Management Devices Market?

The growth in the clot management devices market is driven by several factors, including the rising incidence of cardiovascular diseases, strokes, and venous thromboembolism. An aging global population is a key contributor, as older individuals are at higher risk for blood clots due to slower circulation, comorbid conditions, and prolonged immobility. Additionally, lifestyle factors such as increasing rates of obesity, sedentary lifestyles, and smoking are further exacerbating the prevalence of conditions that require clot management intervention. The market is also propelled by technological advancements that have made clot removal procedures safer, quicker, and more accessible. Innovations in mechanical thrombectomy devices, such as stent retrievers and aspiration systems, have drastically improved patient outcomes, particularly in stroke management. The growing adoption of minimally invasive procedures, which offer reduced recovery times and fewer complications compared to traditional surgery, is another major driver of market expansion. Moreover, as healthcare providers focus on reducing hospital stays and improving long-term outcomes, there is increased demand for devices that can provide fast, effective clot resolution. Favorable reimbursement policies, particularly in developed healthcare markets, alongside rising awareness among physicians and patients about the importance of timely clot intervention, are further fueling the market. As the incidence of clot-related conditions continues to rise, the demand for advanced clot management devices is expected to grow significantly, driven by these diverse factors.

Select Competitors (Total 11 Featured) -

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Clot Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Propels Demand for Clot Management Devices
    • Increasing Incidence of Venous Thromboembolism (VTE) and Pulmonary Embolism (PE) Drives Market Growth
    • Advancements in Mechanical Thrombectomy Devices Strengthen the Business Case for Clot Removal Technologies
    • Expanding Use of Catheter-Directed Thrombolysis (CDT) Broadens the Addressable Market for Clot Management Solutions
    • Rising Adoption of Minimally Invasive Procedures Fuels Demand for Clot Management Devices
    • Increasing Focus on Stroke Prevention Throws the Spotlight on Effective Thrombectomy Devices
    • Growing Use of Clot Retrieval Devices in Emergency Rooms Accelerates Market Expansion
    • Development of Bioabsorbable Stents and Devices Expands Market Potential for Safer Clot Management
    • Rising Aging Population and Sedentary Lifestyles Sustain Demand for Clot Management Solutions
    • Increased Awareness of Stroke and Heart Attack Prevention Propels Market Growth for Prophylactic Clot Management Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clot Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION